HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

subtilin

a linear type A lantibiotic; peptide produced by Bacillus subtilis; structure given in first source

Also Known As:

subtilin precursor

Networked: 21 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Pore Forming Cytotoxic Proteins
      - Bacteriocins: 556
        subtilin: 21
  - Bacterial Proteins: 394
    - Bacteriocins: 556
      - subtilin: 21

Experts

1.	Dyudbin, Oleg: 1 article (01/2022)
2.	Gimranov, Valiyan: 1 article (01/2022)
3.	Giniyatullin, Ilshat: 1 article (01/2022)
4.	Mirzin, Azamat: 1 article (01/2022)
5.	Skovorodin, Evgeny: 1 article (01/2022)
6.	Alpuche Osorno, J J: 1 article (06/2021)
7.	García-Montalvo, I A: 1 article (06/2021)
8.	Matías-Pérez, D: 1 article (06/2021)
9.	Pérez-Santiago, A D: 1 article (06/2021)
10.	Sánchez Medina, M A: 1 article (06/2021)

Related Diseases

1.	Dyslipidemias (Dyslipidemia) 06/01/2021 - "The objective of this study was to carry out an analysis of the genes involved in the development of dyslipidemias that lead to cardiovascular disease with special emphasis on the proprotein convertase subtilin/kexin type 9 (PCSK9) gene. "
2.	Inflammation (Inflammations) 01/01/2022 - "The objective of this study was to investigate the effect of Subtilin ointment on the hematology of dairy cows when used to treat inflammation and necrotic tissue in the digital area. "
3.	Cardiovascular Diseases (Cardiovascular Disease) 06/01/2021 - "The objective of this study was to carry out an analysis of the genes involved in the development of dyslipidemias that lead to cardiovascular disease with special emphasis on the proprotein convertase subtilin/kexin type 9 (PCSK9) gene. "
4.	Infections 08/01/1947 - "The nature, properties, and toxicity of subtilin, and its chemotherapeutic effect on the course of experimental infections in animals." 03/21/1947 - "Action of Subtilin in Reducing Infection by a Seed-borne Pathogen." 05/01/1946 - "The effect of subtilin in the treatment of experimental infections in animals." 09/01/1949 - "PREPARATION OF A MODIFIED SUBTILIN SUITABLE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER INFECTIONS IN ANIMALS." 10/01/1946 - "Effect of subtilin on the course of experimental anthrax infections in guinea pigs."
5.	Tuberculosis (Tuberculoses) 01/01/1950 - "tuberculosis to antituberculous activity of subtilin." 07/01/1948 - "tuberculosis by subtilin and other chemotherapeutic agents." 09/01/1949 - "PREPARATION OF A MODIFIED SUBTILIN SUITABLE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER INFECTIONS IN ANIMALS." 10/01/1946 - "Antibiotics in experimental tuberculosis (with special reference to subtilin)."

Related Drugs and Biologics

1.	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)
2.	Ointments (Pastes)
3.	Nisin
4.	Anti-Bacterial Agents (Antibiotics)
5.	LDL Receptors (LDL Receptor)
6.	Proteins (Proteins, Gene)
7.	Bacteriocins (Lantibiotics)
8.	Apolipoproteins B (ApoB)
9.	Apolipoproteins
10.	epidermin

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)